vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and James River Group Holdings, Inc. (JRVR). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $167.7M, roughly 1.4× James River Group Holdings, Inc.). James River Group Holdings, Inc. runs the higher net margin — 19.1% vs -35.0%, a 54.1% gap on every dollar of revenue. On growth, James River Group Holdings, Inc. posted the faster year-over-year revenue change (32.4% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-23.6M). Over the past eight quarters, James River Group Holdings, Inc.'s revenue compounded faster (-8.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
CCRN vs JRVR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $167.7M |
| Net Profit | $-82.9M | $32.1M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 14.6% |
| Net Margin | -35.0% | 19.1% |
| Revenue YoY | -23.6% | 32.4% |
| Net Profit YoY | -2109.7% | 149.5% |
| EPS (diluted) | $-2.56 | $0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $167.7M | ||
| Q3 25 | $250.1M | $172.7M | ||
| Q2 25 | $274.1M | $174.8M | ||
| Q1 25 | $293.4M | $172.3M | ||
| Q4 24 | $309.9M | $126.7M | ||
| Q3 24 | $315.1M | $191.5M | ||
| Q2 24 | $339.8M | $188.3M | ||
| Q1 24 | $379.2M | $201.1M |
| Q4 25 | $-82.9M | $32.1M | ||
| Q3 25 | $-4.8M | $1.0M | ||
| Q2 25 | $-6.7M | $4.8M | ||
| Q1 25 | $-490.0K | $9.6M | ||
| Q4 24 | $-3.8M | $-64.8M | ||
| Q3 24 | $2.6M | $-39.4M | ||
| Q2 24 | $-16.1M | $7.6M | ||
| Q1 24 | $2.7M | $15.4M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | 14.6% | ||
| Q3 25 | -2.4% | 1.5% | ||
| Q2 25 | -2.1% | 4.2% | ||
| Q1 25 | -0.3% | 9.3% | ||
| Q4 24 | -1.1% | -57.0% | ||
| Q3 24 | 0.9% | -27.1% | ||
| Q2 24 | -5.7% | 10.7% | ||
| Q1 24 | 0.8% | 16.4% |
| Q4 25 | -35.0% | 19.1% | ||
| Q3 25 | -1.9% | 0.6% | ||
| Q2 25 | -2.4% | 2.7% | ||
| Q1 25 | -0.2% | 5.6% | ||
| Q4 24 | -1.2% | -51.1% | ||
| Q3 24 | 0.8% | -20.6% | ||
| Q2 24 | -4.7% | 4.0% | ||
| Q1 24 | 0.7% | 7.7% |
| Q4 25 | $-2.56 | $0.59 | ||
| Q3 25 | $-0.15 | $-0.02 | ||
| Q2 25 | $-0.20 | $0.06 | ||
| Q1 25 | $-0.02 | $0.16 | ||
| Q4 24 | $-0.13 | $-2.44 | ||
| Q3 24 | $0.08 | $-1.10 | ||
| Q2 24 | $-0.47 | $0.13 | ||
| Q1 24 | $0.08 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $260.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $538.2M |
| Total Assets | $449.0M | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $260.9M | ||
| Q3 25 | $99.1M | $238.8M | ||
| Q2 25 | $81.2M | $220.0M | ||
| Q1 25 | $80.7M | $279.4M | ||
| Q4 24 | $81.6M | $362.3M | ||
| Q3 24 | $64.0M | $359.8M | ||
| Q2 24 | $69.6M | $672.5M | ||
| Q1 24 | $5.2M | $305.5M |
| Q4 25 | $322.8M | $538.2M | ||
| Q3 25 | $408.1M | $503.6M | ||
| Q2 25 | $412.2M | $492.6M | ||
| Q1 25 | $418.2M | $484.5M | ||
| Q4 24 | $419.0M | $460.9M | ||
| Q3 24 | $424.7M | $530.3M | ||
| Q2 24 | $433.3M | $541.8M | ||
| Q1 24 | $462.4M | $539.5M |
| Q4 25 | $449.0M | $4.9B | ||
| Q3 25 | $538.2M | $5.0B | ||
| Q2 25 | $553.8M | $5.0B | ||
| Q1 25 | $576.2M | $4.9B | ||
| Q4 24 | $589.3M | $5.0B | ||
| Q3 24 | $597.4M | $5.0B | ||
| Q2 24 | $602.9M | $4.7B | ||
| Q1 24 | $648.4M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-18.8M |
| Free Cash FlowOCF − Capex | $16.1M | $-23.6M |
| FCF MarginFCF / Revenue | 6.8% | -14.1% |
| Capex IntensityCapex / Revenue | 0.9% | 2.9% |
| Cash ConversionOCF / Net Profit | — | -0.59× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $-17.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-18.8M | ||
| Q3 25 | $20.1M | $34.3M | ||
| Q2 25 | $4.2M | $25.2M | ||
| Q1 25 | $5.7M | $-51.5M | ||
| Q4 24 | $24.2M | $-247.1M | ||
| Q3 24 | $7.5M | $-269.9M | ||
| Q2 24 | $82.4M | $-8.7M | ||
| Q1 24 | $6.0M | $24.1M |
| Q4 25 | $16.1M | $-23.6M | ||
| Q3 25 | $17.9M | $33.7M | ||
| Q2 25 | $2.3M | $24.7M | ||
| Q1 25 | $3.8M | $-52.7M | ||
| Q4 24 | $21.7M | $-252.0M | ||
| Q3 24 | $6.3M | $-270.8M | ||
| Q2 24 | $79.6M | $-9.3M | ||
| Q1 24 | $3.8M | $23.3M |
| Q4 25 | 6.8% | -14.1% | ||
| Q3 25 | 7.2% | 19.5% | ||
| Q2 25 | 0.8% | 14.1% | ||
| Q1 25 | 1.3% | -30.6% | ||
| Q4 24 | 7.0% | -198.9% | ||
| Q3 24 | 2.0% | -141.4% | ||
| Q2 24 | 23.4% | -4.9% | ||
| Q1 24 | 1.0% | 11.6% |
| Q4 25 | 0.9% | 2.9% | ||
| Q3 25 | 0.9% | 0.4% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.6% | 0.7% | ||
| Q4 24 | 0.8% | 3.9% | ||
| Q3 24 | 0.4% | 0.4% | ||
| Q2 24 | 0.8% | 0.3% | ||
| Q1 24 | 0.6% | 0.4% |
| Q4 25 | — | -0.59× | ||
| Q3 25 | — | 33.61× | ||
| Q2 25 | — | 5.29× | ||
| Q1 25 | — | -5.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | -1.14× | ||
| Q1 24 | 2.23× | 1.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
JRVR
| Excess And Surplus Lines | $156.7M | 93% |
| Specialty Admitted Insurance | $10.9M | 7% |
